Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging
NCT03354611Phase 3Terminated
- Sponsor
- Koning
- Start
- Sep 2018
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial, sponsored by Koning. Primary endpoint: Diagnostic Breast Lesion Characterization at 4 weeks. Started Sep 2018; status: terminated.
Beyond the preview
Go deeper on NCT03354611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03354611.